lactulose has been researched along with Cerebral Pseudosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cámara-Lemarroy, CR; Delgado-García, G; Estrada-Bellmann, I; García-Valadez, E; Monreal-Robles, R | 1 |
| Takeuchi, H | 2 |
| Mörl, M | 1 |
2 review(s) available for lactulose and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
[Chronic acquired hepatocerebral degeneration].
Topics: Amino Acids, Branched-Chain; Ammonia; Astrocytes; Basal Ganglia; Brain; Chronic Disease; Dementia; Diagnosis, Differential; Diagnostic Imaging; Hepatolenticular Degeneration; Humans; Lactulose; Manganese | 2004 |
[Chronic acquired(non-Wilsonian) hepatocerebral degeneration(CAHD)].
Topics: Amino Acids, Branched-Chain; Ammonia; Chronic Disease; Hepatolenticular Degeneration; Humans; Lactulose; Liver Diseases; Prognosis | 2000 |
2 other study(ies) available for lactulose and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Anti-ammonia treatment-responsive myoclonus as initial presentation of acquired hepatocerebral degeneration.
Topics: Ammonia; Dipeptides; Female; Hepatolenticular Degeneration; Humans; Lactulose; Middle Aged; Myoclonus | 2018 |
[Main characteristics of the treatment of liver cirrhosis].
Topics: Adolescent; Adult; Ascites; Bed Rest; Bloodletting; Child; Child, Preschool; Cholestyramine Resin; Dietary Fats; Dietary Proteins; Diuretics; Energy Intake; Female; Hemochromatosis; Hepatic Encephalopathy; Hepatolenticular Degeneration; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Penicillamine; Potassium; Vitamin B 12 | 1981 |